Ontvang nu dagelijks onze kooptips!

word abonnee
IEX 25 jaar
Uitgebreid zoeken

Beurscodes, betekenis en hulp bij zoeken

Europa

AEX
Euronext Amsterdam
BRU
Euronext Brussels
PSE
Euronext Paris
LIS
Euronext Lissabon
CHX
CBOE Europe, grote(re) EU aandelen
NAV
Investment Funds (NAV)

Noord-Amerika

NYS
New York Stock Exchange
OTC
CBOE BZX Exchange (US)
TSE
Toronto Stock Exchange

Kunt u een instrument niet vinden?

Zoek dan via de zogenaamde ISIN code. Elk instrument, aandeel etc. heeft een unieke code.

Kies vervolgens - wanneer er meerdere resultaten zijn - de notering op de beurs van uw keuze.

Waar vind ik die ISIN code?

Google de naam van het instrument, aandeel etc. met de toevoeging 'ISIN'.

Als zoeken op ISIN code geen resultaten oplevert hebben wij het instrument of aandeel niet in onze koersendatabase.

desktop iconMarkt Monitor
Markt vandaag Koersen Forum Premium IEX Expert
Home  /   Forum   /   Sopheon   /   Sopheon maart 2022

Sopheon« Terug naar discussie overzicht

Sopheon maart 2022

Volgen
16 Posts
| Omlaag ↓
  3. Bertus S 24 maart 2022 08:03
    Results Statement for the Year Ended 31 December 2021

    Sopheon plc, the international provider of software and services for Enterprise Innovation Management solutions, is pleased to announce its results for the year ended 31 December 2021, together with an outlook for the current year.

    Financial Highlights:

    Revenue of $34.4m, ahead of market expectations in the face of continued COVID challenges, whilst embedding the SaaS transition (2020: $30.0m)
    ARR1 rose from $18.0m at the start of 2021 to $20.7m at the end of the year
    Full year 2022 revenue visibility2 stands at $25.1m (last year at this time: $24.5m)
    Gross retention at 95% (2020: 91.5%)
    Adjusted EBITDA3 of $6.2m (2020: $5.9m) also ahead of market expectations
    Profit before tax of $1.2m (2020: $1.7m) affected by higher amortization and share based payments
    Net cash of $24.2m (2020: $21.7m) and the Group has no debt
    Dividend to be maintained at 3.25p per share (2020: 3.25p)

    Operational Highlights

    10 new customer wins of which 9 were SaaS, driving rising quality of earnings and demonstrating the successful shift to a SaaS model. Looking forward, the license pipeline for new customers approaching 90% SaaS. Another six existing clients (2020: 4) were converted to SaaS as part of the Group’s SaaS Uplift program.
    Acceleration of product investment resulted in a higher delivery pace for enterprise Accolade releases. In parallel, investment in cloud-native solutions, with a first application targeted at expanding the Accolade user community. Initial application to launch mid-2022.
    We stepped up marketing programs and investment significantly in 2021 to extend market reach, prospect engagement and ultimately lead generation. This expanded go-to-market strategy is geared to increase new customer acquisition, reducing reliance on large customers who require particular capabilities, and to address a broader target market in order to improve scalability and predictability.
    The acquisition of ROI Blueprints business added deep project management capability eliminating the need for customer purchase and integration of third-party tools in that area.
    Greg Coticchia was appointed CEO during the year, also introducing new leadership in sales, marketing and product areas.
    Andy Michuda, Chairman, commented: “2021 was a year of new leadership, new processes, new programs, and extensive organizational change, together with solid financial outcomes and an initial acquisition. With the initiation of change behind us and the organizational structure and leadership in place, 2022 is very much focused on accelerating and operationalizing the effectiveness of this change. I believe that the future is bright for Sopheon and for Sopheon shareholders.”

    For further information contact:

    Andy Michuda (Chairman)
    Arif Karimjee (CFO) Sopheon plc + 44 (0) 1276 919 560
    Carl Holmes/ Edward Whiley (Corporate Finance)
    Alice Lane/Sunila de Silva (ECM) finnCap Ltd + 44 (0) 20 7220 0500

    www.sopheon.com/financial-releases/re...

    Bertus S.
  6. Gartje 24 maart 2022 12:12
    Volgens mij waren deze cijfers al bekend, Outlook is waar we ons op moeten richten, en gezien het aantal van aandelen wat in vaste handen is kan die laatste zin niet zo maar gezegd worden. Het vertrouwen dat het er goed uitziet voor de aandeelhouders is voor nu even waar ik vertrouwen uit kan halen. Dus rustig afwachten en hopen op een mooi 2022!,
  8. Tritace 25 maart 2022 22:55
    Vond ik nog een interessant deel in de update en een mogelijkheid om de omzet op te krikken

    We are also moving towards a multi-product future, expanding beyond our enterprise Accolade solution. We have ambitious plans in the product investment area which will take patience and time. Our goals here are to:

    - Continue to advance our flagship Accolade enterprise solution and maintain our market leadership. During 2021, three new versions were released, and we plan an ongoing pace of four per year going forward.

    - Introduce new cloud-based applications providing value to individual and workgroup users in the corporate ecosystem, alongside Accolade’s enterprise value proposition. Initial market introduction of the first application is planned for mid-2022. These applications are intended to be stand-alone solutions that solve individual productivity needs in addition to creating future upsell opportunities for Accolade
  10. Tritace 28 maart 2022 08:33
    quote:

    abc123xyz987 schreef op 24 maart 2022 10:09:

    Inderdaad weinig verassingen. Wel een hoop american-style bla bla tekst.
    De omzetgroei tussen jan 2021 en nu valt mij tegen. Kan natuurlijk door SAAS komen maar had ik hoger ingeschat nu.
    De nieuwe marketing en sales mensen moeten aan de bak!

    Groet ABC
    Vraagje: welke omzetgroei zou jij voor dit jaar "acceptabel" vinden?
  11. Tritace 29 maart 2022 16:15
    Sopheon and The AIM Institute Partner to Redefine Product Innovation Process
    Combining “Fuzzy Front End” of Ideas with New Product Development Phase May Dramatically Boost New Product Success Rates

    MINNEAPOLIS – March 29, 2022 – Sopheon, the leading international provider of software and services for Enterprise Innovation Management solutions, and The AIM Institute, the global leader in B2B voice-of-the-customer (VOC) training and software, today announced a partnership that will ensure customer insights become the cornerstone for a company’s innovation processes. With AIM’s Blueprinter® software automatically flowing into Sopheon’s Accolade® innovation management software, companies will be able to manage innovation and new product development programs based on the customer’s stated business goals.

    www.sopheon.com/news-releases/sopheon...
  13. abc123xyz987 29 maart 2022 23:41
    quote:

    Tritace schreef op 29 maart 2022 16:15:

    Sopheon and The AIM Institute Partner to Redefine Product Innovation Process
    Combining “Fuzzy Front End” of Ideas with New Product Development Phase May Dramatically Boost New Product Success Rates

    www.sopheon.com/news-releases/sopheon...
    Mooi bericht!
16 Posts
|Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Markt Vandaag

Stijgers

instrument koers absoluut verschil relatief verschil
EBUSCO HOLDING 0,920 +0,04 +4,53%
FASTNED 21,200 +0,55 +2,66%
THEON INTERNAT 10,100 +0,24 +2,43%
INPOST 17,220 +0,36 +2,14%
IMCD 139,800 +2,45 +1,78%
Galapagos 24,360 +0,40 +1,67%
B&S Group SA 4,125 +0,07 +1,60%
RENEWI 7,020 +0,11 +1,59%
Eurocommercial Properties 23,200 +0,35 +1,53%
Fagron 18,560 +0,28 +1,53%
Wolters Kluwer 155,550 +2,20 +1,43%
UMG 22,250 +0,30 +1,37%
RELX 43,980 +0,58 +1,34%
UNILEVER PLC 55,220 +0,66 +1,21%
WDP 20,340 +0,22 +1,09%
Accsys 0,560 +0,01 +1,08%
BESI 108,650 +1,15 +1,07%
DSM FIRMENICH AG 105,900 +1,05 +1,00%
ASML 637,400 +5,90 +0,93%
JDE PEET'S 18,520 +0,15 +0,82%
ADYEN NV 1.277,000 +10,00 +0,79%
Kendrion 10,820 +0,08 +0,74%
Philips Koninklijke 25,210 +0,18 +0,72%
ACOMO 17,560 +0,10 +0,57%
Sligro 10,640 +0,06 +0,57%
ASMI 499,100 +2,70 +0,54%
ASR Nederland 45,080 +0,24 +0,54%
KPN 3,619 +0,02 +0,53%
Heineken 70,240 +0,36 +0,52%
AEX 870,56 +4,43 +0,51%
NSI 19,760 +0,10 +0,51%
Sif Holding 12,160 +0,06 +0,50%
SHELL PLC 31,680 +0,16 +0,49%
Avantium 2,160 +0,01 +0,47%
Basic-Fit 21,680 +0,10 +0,46%
Alfen N.V. 11,460 +0,05 +0,44%
Pharming 0,698 +0,00 +0,43%
CTP 14,760 +0,06 +0,41%
Arcadis 62,000 +0,25 +0,40%
ALLFUNDS GROUP 5,185 +0,02 +0,39%
Aegon 5,950 +0,02 +0,34%
CM.COM 6,120 +0,02 +0,33%
SIGNIFY NV 21,360 +0,06 +0,28%
AMX 859,95 +2,06 +0,24%
Ahold Delhaize 32,370 +0,06 +0,19%
Flow Traders 21,700 +0,04 +0,18%
AMG Critical Materials N.V. 14,970 0,00 0,00%
EBUSCO (RIGHT) 0,000 0,00 0,00%
Nedap N.V. 52,000 0,00 0,00%
Vastned 24,100 0,00 0,00%

Dalers

instrument koers absoluut verschil relatief verschil
AZERION 1,242 -0,03 -2,51%
ING 14,624 -0,20 -1,35%
ABN AMRO BANK N.V. 14,655 -0,20 -1,31%
BAM 4,008 -0,05 -1,28%
NX FILTRATION 4,150 -0,05 -1,19%
Aperam 27,300 -0,32 -1,16%
Van Lanschot Kempen NV 42,950 -0,50 -1,15%
JUST EAT TAKEAWAY 14,110 -0,13 -0,88%
PROSUS 37,785 -0,32 -0,84%
Corbion 21,660 -0,16 -0,73%
NN Group 44,550 -0,29 -0,65%
ArcelorMittal 23,760 -0,15 -0,63%
TomTom 5,145 -0,03 -0,58%
SBM Offshore 17,920 -0,10 -0,55%
ForFarmers 3,295 -0,02 -0,45%
HEIJMANS KON 27,800 -0,10 -0,36%
Akzo Nobel 55,480 -0,14 -0,25%
Air France-KLM 7,386 -0,02 -0,24%
AALBERTS NV 33,800 -0,08 -0,24%
RANDSTAD NV 40,210 -0,09 -0,22%
Vopak 45,600 -0,10 -0,22%
EXOR NV 94,150 -0,20 -0,21%
TKH 31,840 -0,06 -0,19%
Wereldhave 14,020 -0,02 -0,14%
Brunel 8,390 -0,01 -0,12%
Fugro 16,850 -0,02 -0,12%
PostNL 1,008 0,00 -0,10%
OCI 11,180 -0,01 -0,04%
ASCX 1.173,56 -0,11 -0,01%
vlag naam koers verschil relatief verschil
AEX 870,40 +4,27 +0,49%
AEX GR 3.417,78 +20,53 +0,60%
Germany40^ 19.095,80 -50,37 -0,26%
FTSE 100 8.212,81 +63,54 +0,78%
EURO50 4.736,20 -33,72 -0,71%
US30^ 43.765,00 -95,20 -0,22%
Nasd100^ 20.657,50 -84,40 -0,41%
US500^ 5.929,22 -21,58 -0,36%
Japan225^ 38.093,50 -128,50 -0,34%
VD-NEW 17,05 -1,35 -7,34%
#/^ Index indications calculated real time, zie disclaimer